BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16778057)

  • 1. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity.
    Uno K; Katagiri H; Yamada T; Ishigaki Y; Ogihara T; Imai J; Hasegawa Y; Gao J; Kaneko K; Iwasaki H; Ishihara H; Sasano H; Inukai K; Mizuguchi H; Asano T; Shiota M; Nakazato M; Oka Y
    Science; 2006 Jun; 312(5780):1656-9. PubMed ID: 16778057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dirty dealing: hepatic vagal afferents reshuffle fat distribution.
    Schwartz GJ
    Cell Metab; 2006 Aug; 4(2):103-5. PubMed ID: 16890537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
    Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
    Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
    Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice.
    Yoshizumi S; Suzuki S; Hirai M; Hinokio Y; Yamada T; Yamada T; Tsunoda U; Aburatani H; Yamaguchi K; Miyagi T; Oka Y
    Metabolism; 2007 Mar; 56(3):420-9. PubMed ID: 17292733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
    Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
    Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training attenuates lipectomy-induced impaired glucose tolerance in rats.
    Coelho DF; Gualano B; Artioli GG; Roschel H; Amano M; Benatti FB; Fernandes T; Bueno CR; Câmara NO; Lancha AH
    Endocr Regul; 2009 Jul; 43(3):107-16. PubMed ID: 19817505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
    Lessard SJ; Rivas DA; Chen ZP; Bonen A; Febbraio MA; Reeder DW; Kemp BE; Yaspelkis BB; Hawley JA
    Diabetes; 2007 Jul; 56(7):1856-64. PubMed ID: 17440174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    Shen KP; Lin HL; Hsieh SL; Kwan AL; Chen IJ; Wu BN
    J Pharm Pharmacol; 2009 Apr; 61(4):517-25. PubMed ID: 19298700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model.
    Lim S; Yoon JW; Choi SH; Cho BJ; Kim JT; Chang HS; Park HS; Park KS; Lee HK; Kim YB; Jang HC
    Metabolism; 2009 Jan; 58(1):8-15. PubMed ID: 19059525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice.
    Mercader J; Ribot J; Murano I; Feddersen S; Cinti S; Madsen L; Kristiansen K; Bonet ML; Palou A
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E184-93. PubMed ID: 19417128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
    Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
    Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic peroxisome proliferator-activated receptor-γ-fat-specific protein 27 pathway contributes to obesity-related hypertension via afferent vagal signals.
    Uno K; Yamada T; Ishigaki Y; Imai J; Hasegawa Y; Gao J; Kaneko K; Matsusue K; Yamazaki T; Oka Y; Katagiri H
    Eur Heart J; 2012 May; 33(10):1279-89. PubMed ID: 21825308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.